Cardiac Repair in a Porcine Model of Acute Myocardial Infarction with Human Induced Pluripotent Stem Cell-Derived Cardiovascular Cells
Swine
Cells
Heart Ventricles
Induced Pluripotent Stem Cells
Myocytes, Smooth Muscle
Myocardial Infarction
Apoptosis
Cardiovascular
Regenerative Medicine
Medical and Health Sciences
Smooth Muscle
Genetics
2.1 Biological and endogenous factors
Animals
Humans
Cell Lineage
Myocytes, Cardiac
Aetiology
Insulin-Like Growth Factor I
Heart Disease - Coronary Heart Disease
Cells, Cultured
Transplantation
Myocytes
Fibrin
Cultured
Stem Cell Research - Induced Pluripotent Stem Cell - Human
Stem Cell Research - Induced Pluripotent Stem Cell
5.2 Cellular and gene therapies
Animal
Myocardium
Endothelial Cells
Cell Differentiation
Cell Biology
Recovery of Function
Biological Sciences
Stem Cell Research
Microspheres
3. Good health
Disease Models, Animal
Heart Disease
Disease Models
Acute Disease
Molecular Medicine
Development of treatments and therapeutic interventions
Cardiac
Developmental Biology
Stem Cell Transplantation
DOI:
10.1016/j.stem.2014.11.009
Publication Date:
2014-12-04T11:45:35Z
AUTHORS (20)
ABSTRACT
Human induced pluripotent stem cells (hiPSCs) hold promise for myocardial repair following injury, but preclinical studies in large animal models are required to determine optimal cell preparation and delivery strategies to maximize functional benefits and to evaluate safety. Here, we utilized a porcine model of acute myocardial infarction (MI) to investigate the functional impact of intramyocardial transplantation of hiPSC-derived cardiomyocytes, endothelial cells, and smooth muscle cells, in combination with a 3D fibrin patch loaded with insulin growth factor (IGF)-encapsulated microspheres. hiPSC-derived cardiomyocytes integrated into host myocardium and generated organized sarcomeric structures, and endothelial and smooth muscle cells contributed to host vasculature. Trilineage cell transplantation significantly improved left ventricular function, myocardial metabolism, and arteriole density, while reducing infarct size, ventricular wall stress, and apoptosis without inducing ventricular arrhythmias. These findings in a large animal MI model highlight the potential of utilizing hiPSC-derived cells for cardiac repair.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (28)
CITATIONS (397)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....